Search results
NGM Biopharmaceuticals (NGM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 2 years agoNGM Biopharmaceuticals (NGM) possesses the right combination of the two key ingredients for a likely...
Institutional owners may consider drastic measures as NGM Biopharmaceuticals, Inc.'s (NASDAQ:NGM)...
Simply Wall St. via Yahoo Finance· 10 months agoKey Insights Significantly high institutional ownership implies NGM Biopharmaceuticals' stock price...
Great week for NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) institutional investors after losing 75%...
Simply Wall St. via Yahoo Finance· 4 months agoKey Insights Given the large stake in the stock by institutions, NGM Biopharmaceuticals' stock price...
NGM Biopharmaceuticals (NGM) Soars 6.8%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 2 years agoNGM Biopharmaceuticals (NGM) saw its shares surge in the last session with trading volume being...
NGM Biopharmaceuticals (NGM) Reports Q4 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 2 months agoNGM Biopharmaceuticals (NGM) delivered earnings and revenue surprises of 10.81% and 91.75%,...
NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) is definitely on the radar of institutional investors who...
Simply Wall St. via Yahoo Finance· 1 year agoTo get a sense of who is truly in control of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM), it is...
Insiders Give Up US$292k As NGM Biopharmaceuticals Stock Drops To US$1.31
Simply Wall St. via Yahoo Finance· 8 months agoInsiders who acquired US$462k worth of NGM Biopharmaceuticals, Inc.'s (NASDAQ:NGM) stock at an...
Shareholders in NGM Biopharmaceuticals (NASDAQ:NGM) have lost 42%, as stock drops 6.5% this past...
Simply Wall St. via Yahoo Finance· 2 years agoInvestors can approximate the average market return by buying an index fund. While individual stocks...
How Much Upside is Left in NGM Biopharmaceuticals (NGM)? Wall Street Analysts Think 462%
Zacks via Yahoo Finance· 1 year agoThe mean of analysts' price targets for NGM Biopharmaceuticals (NGM) points to a 461.7% upside in...
Lead Independent Director David Goeddel Just Bought 68% More Shares In NGM Biopharmaceuticals, Inc....
Simply Wall St. via Yahoo Finance· 2 years agoPotential NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) shareholders may wish to note that the Lead...